Log in
TSE:CXR

Concordia International Corp. (CXR.TO) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume73,541 shs
Average Volume4,054 shs
Market CapitalizationC$1.22 billion
P/E Ratio0.07
Dividend YieldN/A
BetaN/A
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016. Concordia International Corp. is headquartered in Oakville, Canada.
Read More
Concordia International Corp. (CXR.TO) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-8425150
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$569.62 million
Book ValueC$6.08 per share

Profitability

Miscellaneous

Market CapC$1.22 billion
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive CXR News and Ratings via Email

Sign-up to receive the latest news and ratings for CXR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Concordia International Corp. (CXR.TO) (TSE:CXR) Frequently Asked Questions

What stocks does MarketBeat like better than Concordia International Corp. (CXR.TO)?

Wall Street analysts have given Concordia International Corp. (CXR.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Concordia International Corp. (CXR.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Concordia International Corp. (CXR.TO)'s key competitors?

What other stocks do shareholders of Concordia International Corp. (CXR.TO) own?

Who are Concordia International Corp. (CXR.TO)'s key executives?

Concordia International Corp. (CXR.TO)'s management team includes the following people:
  • Mr. Graeme Neville Duncan, CEO & Director (Age 44)
  • Mr. Karl Ian Belk, Chief Operations Officer
  • Mr. Adeel Ahmad, Chief Financial Officer (Age 44)
  • Mr. Adam Peeler, VP of Investor Relations & Communications
  • Mr. Robert Sully, Gen. Counsel

What is Concordia International Corp. (CXR.TO)'s stock symbol?

Concordia International Corp. (CXR.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CXR."

How do I buy shares of Concordia International Corp. (CXR.TO)?

Shares of CXR and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Concordia International Corp. (CXR.TO)?

Concordia International Corp. (CXR.TO) has a market capitalization of C$0.00 and generates C$569.62 million in revenue each year.

What is Concordia International Corp. (CXR.TO)'s official website?

The official website for Concordia International Corp. (CXR.TO) is concordiarx.com.

How can I contact Concordia International Corp. (CXR.TO)?

Concordia International Corp. (CXR.TO)'s mailing address is 277 Lakeshore Rd E Suite 302, OAKVILLE, ON L6J 1H9, Canada. The company can be reached via phone at +1-905-8425150.

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.